StreetInsider.com News Articles

Form 8-K IR-Med, Inc. For: Sep 14

Tue, 15 Sep 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260915/27064871.html

Form 8-K IR-Med, Inc. For: Jun 03

Wed, 03 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260603/26598778.html

Form 8-K IR-Med, Inc. For: Jun 03

Wed, 03 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260603/26598778.html

Form 8-K IR-Med, Inc. For: Feb 04

Thu, 05 Feb 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260205/25954784.html

Form 8-K IR-Med, Inc. For: Feb 04

Thu, 05 Feb 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260205/25954784.html

Form 8-K IR-Med, Inc. For: Dec 07

Fri, 12 Dec 2025 16:06:00 -0400

si-local-file:///var/storage/secattach/20251212/25734540.html

Form 8-K IR-Med, Inc. For: Dec 07

Fri, 12 Dec 2025 16:06:00 -0400

si-local-file:///var/storage/secattach/20251212/25734540.html

IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment

Mon, 03 Nov 2025 16:30:00 -0400

DiaSafe™ technology for non-invasive DFU risk assessment and early intervention*
The DFU treatment market is estimated to be approximately$10 billion globally¹

Rosh Pina, Israel--(Newsfile Corp. - November 3, 2025) - IR-MED Ltd. (OTCQB: IRME) (the "Company" or "IR-Med"), a pioneer in artificial intelligence ("AI")-driven, non-invasive infrared spectrographic medical device developer, today announced that it has initiated the first-in-human clinical trial of its DiaSafe™ device – built on the proven "sensing the invisible" platform – specifically targeting DFUs. This milestone marks a critical step toward transforming DFU assessment and prevention across diverse patient populations.

Key Highlights of the Trial Launch

The DiaSafe device is

IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment

Mon, 03 Nov 2025 16:30:00 -0400

DiaSafe™ technology for non-invasive DFU risk assessment and early intervention*
The DFU treatment market is estimated to be approximately$10 billion globally¹

Key Highlights of the Trial Launch

The DiaSafe device is

IR-MED's Key Clinical and Media Milestones

Mon, 27 Oct 2025 16:05:00 -0400

PressureSafe(TM) clinical results presented to global nursing leaders; the Company engages with U.S. investment community and national media in parallel visibility push

Rosh Pina, Israel--(Newsfile Corp. - October 27, 2025) - IR-Med Inc. (OTCQB: IRME), (the "Company" or "IR-Med"), a medical technology company developing a non-invasive, AI-powered infrared spectroscopy platform for the assessment of pressure injuries and diabetic ulcers, today announced a series of recent milestones that highlight the Company's expanding visibility within the healthcare, investment, and media communities.

Podium Presentation at Magnet & Pathway 2025 Conference - October 7, 2025, Atlanta, GA^[1]

IR-MED's technology was showcased at the Magnet & Pathway 2025

IR-MED's Key Clinical and Media Milestones

Mon, 27 Oct 2025 16:05:00 -0400

PressureSafe(TM) clinical results presented to global nursing leaders; the Company engages with U.S. investment community and national media in parallel visibility push
Rosh Pina, Israel--(Newsfile Corp. - October 27, 2025) - IR-Med Inc. (OTCQB: IRME), (the "Company" or "IR-Med"), a medical technology company developing a non-invasive, AI-powered infrared spectroscopy platform for the assessment of pressure injuries and diabetic ulcers, today announced a series of recent milestones that highlight the Company's expanding visibility within the healthcare, investment, and media communities.
Podium Presentation at Magnet & Pathway 2025 Conference - October 7, 2025, Atlanta, GA^[1]
IR-MED's technology was showcased at the Magnet & Pathway 2025

Form 8-K IR-Med, Inc. For: Sep 22

Mon, 22 Sep 2025 08:01:00 -0400
si-local-file:///var/storage/secattach/20250922/25358465.html

Form 8-K IR-Med, Inc. For: Sep 22

Mon, 22 Sep 2025 08:01:00 -0400
si-local-file:///var/storage/secattach/20250922/25358465.html

IR-MED Investor Update Letter - Sept-2025

Tue, 16 Sep 2025 16:05:00 -0400

Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company"), a developer of non-invasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, today published an investor update.
Dear Valued Investors,
As we enter September 2025, in addition to Q2 financial reports and to the 8K recently published, I find it appropriate to update you on the developments within our Company. As you will see from the information below, the Company has achieved meaningful milestones that could bring it closer to the start of commercial operations. In order to move from potential to realization,

IR-MED Investor Update Letter - Sept-2025

Tue, 16 Sep 2025 16:05:00 -0400

Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company"), a developer of non-invasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, today published an investor update.
Dear Valued Investors,
As we enter September 2025, in addition to Q2 financial reports and to the 8K recently published, I find it appropriate to update you on the developments within our Company. As you will see from the information below, the Company has achieved meaningful milestones that could bring it closer to the start of commercial operations. In order to move from potential to realization,

Form 8-K IR-Med, Inc. For: Sep 05

Thu, 11 Sep 2025 16:06:00 -0400
si-local-file:///var/storage/secattach/20250911/25325324.html

Form 8-K IR-Med, Inc. For: Sep 05

Thu, 11 Sep 2025 16:06:00 -0400
si-local-file:///var/storage/secattach/20250911/25325324.html

Form 8-K IR-Med, Inc. For: Aug 28

Wed, 03 Sep 2025 06:05:00 -0400
si-local-file:///var/storage/secattach/20250903/25287673.html

Form 8-K IR-Med, Inc. For: Aug 28

Wed, 03 Sep 2025 06:05:00 -0400
si-local-file:///var/storage/secattach/20250903/25287673.html

Form 10-Q IR-Med, Inc. For: Jun 30

Thu, 14 Aug 2025 16:16:00 -0400
si-local-file:///var/storage/secattach/20250814/25206721.html

Form 10-Q IR-Med, Inc. For: Jun 30

Thu, 14 Aug 2025 16:16:00 -0400
si-local-file:///var/storage/secattach/20250814/25206721.html

Form 8-K IR-Med, Inc. For: Aug 03

Thu, 07 Aug 2025 16:07:00 -0400
si-local-file:///var/storage/secattach/20250807/25167404.html

Form 8-K IR-Med, Inc. For: Aug 03

Thu, 07 Aug 2025 16:07:00 -0400
si-local-file:///var/storage/secattach/20250807/25167404.html

Form 8-K IR-Med, Inc. For: Jul 23

Tue, 29 Jul 2025 16:22:00 -0400
si-local-file:///var/storage/secattach/20250729/25114918.html

Form 8-K IR-Med, Inc. For: Jul 23

Tue, 29 Jul 2025 16:22:00 -0400
si-local-file:///var/storage/secattach/20250729/25114918.html